Navigation Links
Largest Acellular Dermal Allografts Available for Abdominal Wall Reconstruction Introduced at AWR 2011
Date:6/16/2011

WASHINGTON, June 16, 2011 /PRNewswire/ -- The largest human dermal allograft available on the market today for hernia and abdominal wall repair will be introduced at the AWR meeting here this week.  The Musculoskeletal Transplant Foundation (MTF), the nation's leading tissue bank, is introducing FlexHD acellular hydrated dermal matrix 20 cm x 30 cm grafts just months after releasing 20 cm x 25 cm grafts.

FlexHD large grafts can help with the most challenging general surgical and trauma procedures --

  • Reduces the need to suture smaller sheets together. The 20 cm x 30 cm size is the largest out-of-package to patient human acellular hydrated dermal matrix available for use in large abdominal wall cases and trauma.
  • FlexHD is ready when you are: it is prehydrated, so there is no waiting time, no more wrong size and no wasted time or tissue.
  • No stretching means no pre-stretching required and post-operative laxity is reduced.
  • It is natural, so you can avoid the concerns associated with xenograft products. FlexHD biologic and biomechanical properties match the human anatomy and provide rapid revascularization.
  • FlexHD superior strength and resistance to stretching make it an ideal solution for hernia repair.
  • FlexHD passes rigorous safety testing including USP <71> sterility tests. With over four million grafts distributed since its inception, MTF possesses an unrivaled safety record.

To inquire about the new sizes, contact MTF customer service at 800-433-6576 or info@mtf.org.

The Musculoskeletal Transplant Foundation, a non-profit organization, is a national consortium comprised of leading academic medical institutions, organ procurement organizations and tissue recovery organizations.  Since its inception in 1987, MTF has received tissue from more than 80,000 donors.

*FlexHD is represented by Ethicon, Inc., a Johnson & Johnson Company.

FlexHD is a trademark of Musculoskeletal Transplant Foundation.

For further information
Cindy Gordon, Insight Communication
609-252-1300


'/>"/>
SOURCE Musculoskeletal Transplant Foundation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Georgia Reproductive Specialists Participates in Largest-Ever In Vitro Fertilization Clinical Trial in the World
2. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
3. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
4. Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies
5. Raydiance Collaborates With Rutgers University and Nations Largest Tissue Bank to Develop Innovative Tissue Processing Approaches
6. Video: New Results From One of the Worlds Largest Breast Cancer Trials Herald Hope for Thousands of Women
7. Universite de Montreal Researchers Simulate Worlds Largest Heart Model Using SGI Technology
8. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study
9. Safety and Efficacy Results Presented From Largest Prospective Controlled Clinical Study of Ulcerative Colitis
10. The Largest Ever Study of Diabetes Shows Intensive Glucose Control Reduces Serious Complications
11. Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/10/2017)... , May 10, 2017  The Corporate ... or employees of sleep therapy clinics to call ... sleep therapy clinic is involved in a substantial ... interested in hearing from an employee of a ... in a kickback scheme to provide medical practice groups ...
(Date:5/10/2017)... CSSi, the global leader in patient recruitment, ... is proud to announce the launch of its newly ... both enriched content and a customized layout that provides ... already well-established position as the top global patient recruitment ... months of hard work, we are delighted to officially ...
(Date:5/9/2017)... WASHINGTON , May 9, 2017  Demonstrating ... the board of directors for the Pharmaceutical Research ... criteria for membership. Biopharmaceutical companies will now have ... in order to be eligible to join PhRMA. ... criteria, the board is sending a clear message ...
Breaking Medicine Technology:
(Date:5/27/2017)... ... , ... In any business, follow up is critical to success. It is ... presenting treatment, there will always be some patients who can’t or won’t make a ... practices when it comes to presenting treatment. After the patient leaves, most practices ...
(Date:5/27/2017)... ... May 27, 2017 , ... Most us are familiar ... a new study from the Osteoarthritis Initiative shows that certain people who ... Knowing this in advance may give doctors the opportunity to treat patients before the ...
(Date:5/26/2017)... YORK, NY (PRWEB) , ... May 26, 2017 ... ... Board (SAB) met this week to review more than eighty-nine grant submissions ... experienced and emerging young scientists in the Parkinson’s field.     , The American Parkinson ...
(Date:5/26/2017)... , ... May 26, 2017 , ... ... announce a new educational seminar to focus on current legislative activity and the ... will begin at 1 p.m. Sunday, Sept. 10, and will continue through Monday, ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... ... integration of the CareFusion NOX-T3 portable sleep monitor with its Somnoware Sleep Device ... consistent, browser-based interface for diagnostic device operations. With this platform, initializing devices and ...
Breaking Medicine News(10 mins):